Insider Transactions in Q1 2021 at Trans Medics Group, Inc. (TMDX)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 15
2021
|
Stephen Gordon Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,000
-100.0%
|
$390,000
$39.81 P/Share
|
|
Mar 15
2021
|
Stephen Gordon Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$0
$0.67 P/Share
|
|
Mar 11
2021
|
John F Carey VP of Operations |
SELL
Open market or private sale
|
Direct |
3,200
-100.0%
|
$118,400
$37.5 P/Share
|
|
Mar 10
2021
|
Waleed H Hassanein President & CEO |
SELL
Open market or private sale
|
Direct |
35,007
-4.71%
|
$1,190,238
$34.21 P/Share
|
|
Mar 10
2021
|
Waleed H Hassanein President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
35,007
+8.56%
|
$70,014
$2.21 P/Share
|
|
Mar 08
2021
|
Tamer I Khayal Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
20,000
-30.27%
|
$640,000
$32.0 P/Share
|
|
Mar 08
2021
|
Tamer I Khayal Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+23.24%
|
$0
$0.28 P/Share
|
|
Mar 05
2021
|
Tamer I Khayal Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
20,000
-16.17%
|
$600,000
$30.77 P/Share
|
|
Mar 05
2021
|
Tamer I Khayal Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+13.49%
|
$0
$0.34 P/Share
|
|
Feb 16
2021
|
Stephen Gordon Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,000
-100.0%
|
$310,000
$31.33 P/Share
|
|
Feb 16
2021
|
Stephen Gordon Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$0
$0.67 P/Share
|
|
Feb 09
2021
|
John F Sullivan VP of Quality & Engineering |
SELL
Open market or private sale
|
Direct |
8,600
-22.53%
|
$283,800
$33.48 P/Share
|
|
Feb 09
2021
|
John F Sullivan VP of Quality & Engineering |
BUY
Exercise of conversion of derivative security
|
Direct |
8,600
+30.68%
|
$0
$0.28 P/Share
|
|
Feb 09
2021
|
James R Tobin |
SELL
Open market or private sale
|
Indirect |
10,168
-1.17%
|
$335,544
$33.49 P/Share
|
|
Feb 09
2021
|
Abrams Capital Management, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
786,664
-23.06%
|
$25,959,912
$33.32 P/Share
|
|
Feb 08
2021
|
Stephen Gordon Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,000
-100.0%
|
$250,000
$25.01 P/Share
|
|
Feb 08
2021
|
Stephen Gordon Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,429
+50.0%
|
$0
$0.67 P/Share
|
|
Feb 08
2021
|
Abrams Capital Management, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
88,483
-2.53%
|
$2,300,558
$26.24 P/Share
|
|
Jan 19
2021
|
John F Sullivan VP of Quality & Engineering |
SELL
Open market or private sale
|
Direct |
9,617
-47.04%
|
$211,574
$22.12 P/Share
|
|
Jan 19
2021
|
John F Sullivan VP of Quality & Engineering |
BUY
Exercise of conversion of derivative security
|
Direct |
9,617
+31.99%
|
$0
$0.39 P/Share
|
|
Jan 05
2021
|
Waleed H Hassanein President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
123,414
+26.7%
|
$0
$0.39 P/Share
|
|
Jan 04
2021
|
Stephen Gordon Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,184
-12.39%
|
$23,680
$20.0 P/Share
|